Chen Lili, chairman of Mingde Biologics: In the fight against the virus, biomedical companies must play a forward

(The picture shows that on March 23, Mingde Bio partially resumed work.) Photo courtesy of Zhang Honghua)

Yangtze River Daily - Yangtze River Network, September 8 (reporter Li Jia) Chen Lili, chairman of Mingde Biology, an enterprise in the East Lake High-tech Zone, introduced that she watched the national commendation conference for fighting the new crown pneumonia epidemic and felt encouraged. She introduced that in the fight against the virus, effective identification is the first step, and the biopharmaceutical companies that do testing must play a front. As early as the beginning of the epidemic, Matilda believed that enterprises had the ability and obligation to act quickly, quickly invested in research and development, and developed products to help fight the epidemic at home and abroad. Whether it is the biological battlefield against the virus or the innovative track for the development of biomedicine, Mingde Biology is ready for independent innovation. This year, the company's R&D investment has achieved eight consecutive years of growth, and it has continued to struggle for the rise of China's medicine.

【Editor: Dai Rong Intern: Yu Kejing】